Gentamicin

Dose Adult- NB; individualisation is critical because of its low therapeutic index

Usual dosage ranges: I.M., I.V.: Conventional: 1-2.5 mg/kg/dose every 8-12 hours; (75-150 mg / day)

To ensure adequate peak concentrations early in therapy, higher initial dosage may be considered

in selected patients when extracellular water is increased (edema, septic shock, postsurgical, or trauma)

Once daily: 4-7 mg/kg/dose once daily;

some clinicians recommend this approach for all patients with normal renal function;

this dose is at least as efficacious with similar, if not less, toxicity than conventional dosing

Intrathecal: 4-8 mg/day

Indication-specific dosing: I.M., I.V.:

Brucellosis: 240 mg (I.M.) daily or 5 mg/kg (I.V.) daily for 7 days; either regimen recommended in combination with doxycycline

Cholangitis: 4-6 mg/kg once daily with ampicillin

Diverticulitis (complicated): 1.5-2 mg/kg every 8 hours (with ampicillin and metronidazole)

Endocarditis: Treatment: 3 mg/kg/day in 1-3 divided doses

Meningitis Enterococcus sp or Pseudomonas aeruginosa:

I.V.: Loading dose 2 mg/kg, then 1.7 mg/kg/dose every 8 hours (administered with another bacteriocidal drug)

Pelvic inflammatory disease: Loading dose: 2 mg/kg, then 1.5 mg/kg every 8 hours

Alternate therapy: 4.5 mg/kg once daily

Plague ( Yersinia pestis ): Treatment: 5 mg/kg/day, followed by postexposure prophylaxis with doxycycline

Pneumonia, hospital- or ventilator-associated: 7 mg/kg/day (with antipseudomonal beta-lactam or carbapenem)

Synergy (for gram-positive infections): 3 mg/kg/day in 1-3 divided doses (with ampicillin)

Tularemia: 5 mg/kg/day divided every 8 hours for 1-2 weeks

Urinary tract infection: 1.5 mg/kg/dose every 8 hours

Dosing: Pediatric

7.5mg/kg OD if >7days old.

Neonatal; <2kg=3mg/kg OD {=} >2kg 5mg/kg OD

Use of ideal body weight (IBW) for determining the mg/kg/dose appears to be more

accurate than dosing on the basis of total body weight (TBW).

In morbid obesity, dosage requirement may best be estimated using a dosing weight of IBW + 0.4 (TBW - IBW).

Initial and periodic plasma drug levels (eg, peak and trough with c

onventional dosing) should be determined, particularly in critically-ill patients with serious infections

or in disease states known to significantly alter aminoglycoside pharmacokinetics

(eg, cystic fibrosis, burns, or major surgery).

Usual dosage ranges: I.M., I.V.:

Infants and Children <5 years: 2.5 mg/kg/dose every 8 hours*

Children ≥5 years: 2-2.5 mg/kg/dose every 8 hours*

*Note: Higher individual doses and/or more frequent intervals (eg, every 6 hours)

may be required in selected clinical situations (cystic fibrosis) or serum levels document the need.

Indication-specific dosing:

Meningitis: Neonates: I.V.:

0-7 days of age: <2000 g: 2.5 mg/kg every 18-24 hours; >2000 g: 2.5 mg/kg every 12 hours

8-28 days of age: <2000 g: 2.5 mg/kg every 8-12 hours; >2000 g: 2.5 mg/kg every 8 hours

Brands.

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Bactigen FDC. Ltd Wessex Pharmaceuticals Limited 0.30% 5ml eye drops per ml KES 40
Beagenta ICI Pakistan Surgipharm Ltd 0.30% 10ml eye drops per ml KES 75
Colircusi Gentamicin Cusi Alcon Pan Pharmaceuticals Ltd 0.30% 10ml eye drops per ml KES 260
Garamycin Schering-Plough (See also Essex Chemie) Laborex Kenya Eurapharma Ltd 0.30% 10ml eye drops per ml KES 297.00
Garamycin Schering-Plough (See also Essex Chemie) Laborex Kenya Eurapharma Ltd 15gm Cream KES 324
Garamycin Schering-Plough (See also Essex Chemie) Laborex Kenya Eurapharma Ltd 15gm Ointment KES 324
Gentasone Caplin Point Lab Ltd. Medisel Kenya Ltd 10ml eye drops per ml KES 15
Gentosep Beximco Pharma Madawa Pharmaceuticals Ltd. 3mg 15gm Cream KES 143.00
Ivygentacin Ivee Aqua EPZ Ltd. Harley's Limited 0.30% 10ml eye drops per ml KES 17.00
Medigenta Medivet Products Ltd Medivet Products Ltd. 15gm Cream KES POR
Wencin West Coast Pharmaceuticals Works Ltd Ray Pharmaceuticals Ltd 10ml eye drops per ml KES 26.25
Oftamolosa Cusi Gentamycin Cusi Alcon Pan Pharmaceuticals Ltd 10 Tablet per tablet KES 65.7
Oftamolosa Cusi Gentamycin Cusi Alcon Pan Pharmaceuticals Ltd 0.30% 5g Ointment KES 360.00
Dawagenta Dawa Limited Dawa Limited 80mg 2ml Injection KES 5.00
Genacyn Square Pharmaceuticals Ltd ACE Pharmaceuticals Ltd 20mg 10 Injection per ml KES 130.00
Genacyn Square Pharmaceuticals Ltd ACE Pharmaceuticals Ltd 80mg 10 Injection per vial KES 180.00
Gentacil Globe Pharmacy Ltd., Globe Pharmacy Ltd., 0.30% 5ml eye drops per ml KES 16.50
Gentacil Globe Pharmacy Ltd., Globe Pharmacy Ltd., 0.30% 10ml eye drops per ml KES 18.00

Gentamicin more info
Mode Of Action

irreversibly binds to 30s sub-unit of bacterial ribosomes; blocks recognition step in protein synthesis and causes growth inhibition.

Drug Indication Sensitive UTI, RTI, severe systemic infections, bone and tissue infections, eye infections.
Precautions Avoid use with potent diuretics, nephrotoxic and neurotoxic drugs, impaired renal functions, myasthenia gravis.
Contra-Indications Pregnancy and lactation, myasthenia gravis
Side Effects Vestibular and auditory damage, nephrotoxicity; rarely, hypomagnesaemia on prolonged therapy, antibiotic-associated colitis, stomatitis; also reported, nausea, vomiting, rash, blood disorders.
Dosage Adult: Multiple daily dose regimen, by intramuscular or by slow intravenous injection over at least 3 minutes or by intravenous infusion, 3-5 mg/kg daily (in divided doses every 8 hours. Endocarditis (in combination with other antibacterials, adult 1 mg/kg every 8 hours Once daily dose regimen, by intravenous infusion, initially 5-7 mg/kg, then adjust according to serum-gentamicin concentration. By intrathecal injection, seek specialist advice, 1 mg daily (increased if necessary to 5 mg daily). Child: Neonatal sepsis, extended interval dose regimen by slow intravenous injection or intravenous infusion. Neonate less than 32 weeks postmenstrual age 4-5 mg/kg every 36 hours. Neonate 32 weeks and over postmenstrual age 4-5 mg/kg every 24 hours. Multiple daily dose regimen by slow intravenous injection. Neonate less than 29 weeks postmenstrual age 2.5 mg/kg every 24 hours. Neonate 29-35 weeks postmenstrual age 2.5 mg/kg every 18 hours Neonate over 35 weeks postmenstrual age 2.5 mg/kg every 12 hours. Septicaemia, meningitis and other CNS infections, biliary-tract infection, acute pyelonephritis, endocarditis, pneumonia in hospital patients, adjunct in listerial meningitis. Once daily dose regimen (not for endocarditis or meningitis) by intravenous infusion. Child 1 month-18 years initially 7 mg/kg, then adjusted according to serum-gentamicin concentration. Multiple daily dose regimen by intramuscular or by slow intravenous injection over at least 3 minutes. Child 1 month-12 years 2.5 mg/kg every 8 hours Child 12-18 years 2 mg/kg every 8 hours. Pseudomonal lung infection in cystic fibrosis:By slow intravenous injection over at least 3 minutes or by intravenous infusion. Child 1 month-18 years 3 mg/kg every 8 hours. Bacterial ventriculitis and CNS infection (supplement to systemic therapy) By intrathecal or intraventricular injection, seek specialist advice Neonate seek specialist advice Child 1 month-18 years:1 mg daily (increased if necessary to 5 mg daily). Note: Onl
Pregnancy Category Category D
Pregnancy Category Description Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Aminoglycosides